Creatine monohydrate pilot in Alzheimer's: Feasibility, brain creatine, and cognition
Creatine monohydrate supplementation was feasible in patients with Alzheimer's disease.Creatine monohydrate was associated with increased brain total creatine.Creatine monohydrate was associated with improvements in cognition.Efficacy of creatine monohydrate in Alzheimer's disease should be studied further.
Authors
- Debra K. Sullivan (ORCID: https://orcid.org/0000-0003-1694-5829)
- Aaron N. Smith (ORCID: https://orcid.org/0000-0002-2450-8365)
- Phil Lee (ORCID: https://orcid.org/0000-0002-2087-8887)
- In‐Young Choi (ORCID: https://orcid.org/0000-0003-1804-6747)
- Russell Howard Swerdlow (ORCID: https://orcid.org/0000-0003-2948-7230)
- Matthew K. Taylor (ORCID: https://orcid.org/0000-0002-4368-2705)
- Jeffrey Murray Burns (ORCID: https://orcid.org/0000-0001-7609-8954)
- Emma Kelly (ORCID: https://orcid.org/0000-0003-3040-3874)
Institutions
- University of Kansas (US)
- Shawnee Mission Medical Center (US)
- University of Kansas Medical Center (US)
- Imaging Center (US)
Publication Details
- Journal
- Alzheimer s & Dementia Translational Research & Clinical Interventions
- Published
- 2025-04-01
- DOI
- https://doi.org/10.1002/trc2.70101
- Citations
- 9
- Primary Topic
- Muscle metabolism and nutrition
- Type
- article
- Field-Weighted Citation Impact
- 10.36
Funders
- Alzheimer's Association
- National Institutes of Health
- National Center for Advancing Translational Sciences